SEC Form 4 · accession 0002127744-26-000002
ALTERITY THERAPEUTICS LTD · ATHE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julian Michael Babarczy
Director
Period of report
Jun 15, 2026
Accepted (ET)
Jun 23, 2026 · 7:57 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001131343
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Unlisted option exp 15 Jun 2031 | $1.00 | Jun 15, 2026 | A | 2,000,000 | A | Jun 15, 2026 | Jun 15, 2031 | Ordinary shares | 2,000,000 | 2,000,000 | I |